Effect of Liraglutide on Cardiometabolic Risk Profile in People with Coronary Artery Disease with or without Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Whether liraglutide use improves cardiometabolic risk factors in different subsets of subjects with coronary artery disease (CAD) remains unclear. In a systematic review and meta-analysis, we quantified the effects of liraglutide on cardiometabolic risk profile in subjects with CAD with...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowrouzi-Sohrabi, Peyman, Soroush, Negin, Tabrizi, Reza, Shabani-Borujeni, Mojtaba, Rezaei, Shahla, Jafari, Fatemeh, Hosseini-Bensenjan, Mahnaz, Stricker, Bruno H., van Hoek, Mandy, Ahmadizar, Fariba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039463/
https://www.ncbi.nlm.nih.gov/pubmed/33854433
http://dx.doi.org/10.3389/fphar.2021.618208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039463/
https://www.ncbi.nlm.nih.gov/pubmed/33854433
http://dx.doi.org/10.3389/fphar.2021.618208

Ejemplares similares